Analyst Ratings for Summit Therapeutics plc (SMMT)
SMMT Rating Summary
SMMT Price Target Summary
- Highest: $40.00 (Citizens)
- Lowest: $11.90 (Bernstein SocGen Group)
- Average: $26.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$26.29 (+85.7%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$26.29 (+85.7%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2026 | Bernstein SocGen Group | Jeffrey Walch | Upgrade | Market Perform (Underperform) |
11.90 (9.80) |
13.16 (14.16) |
7.6% | Details |
| 8/12/2026 | Leerink | Daina Graybosch | Upgrade | Market Perform (Underperform) |
13.00 (N/A) |
15.11 (14.16) |
-6.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
